Management of inflammatory bowel disease in the pregnant patient

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

271

HTML

2336

Tables (1-3)

216

Sum=2823

Mar 7, 2008 (publication date) through Nov 8, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Mar 7, 2008; 14(9): 1326-1332
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1326

Table 2 FDA classes of medications used to treat IBD

FDA class	Medications
B	5-Aminosalicylic acid preparations (sulfasalazine, mesalamine, balsalazide); metronidazole, amoxicillin/clavulanic acid; infliximab; adalimumab
C	5-Aminosalicylic acid preparations (Olsalazine); fluoroquinolones; corticosteroids; bisphosphonates; cyclosporin; tacrolimus
D	Azathioprine and 6-MP
X	Methotrexate; thalidomide

Citation: Habal FM, Ravindran NC. Management of inflammatory bowel disease in the pregnant patient. World J Gastroenterol 2008; 14(9): 1326-1332
URL: https://www.wjgnet.com/1007-9327/full/v14/i9/1326.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1326